4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-115693
Options or other derivatives
- Chief Financial Officer acquired 33,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prasad Raju Chief Financial Officer | 2024-10-16 | Grant or award · Stock Option (Right to Buy) | +18,333 | 18,333 | D: show line 1 in the form | ||
| Prasad Raju Chief Financial Officer | 2024-10-16 | Grant or award · Restricted Stock Units | +15,000 | 15,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…